1970EGP
- Active ingredient
- liraglutide
- Strength
- 18mg/3ml
- Form
- ampoule
- Manufacturer
- novonordisk
- Route
- injection
Uses
Adjunct to diet and exercise for type 2 diabetes mellitus; also used in weight-management indications depending on formulation.
Do not use if
Personal or family history of medullary thyroid carcinoma, MEN2, or serious hypersensitivity.
Side effects
Nausea, vomiting, diarrhea, decreased appetite, hypoglycemia in some settings.
Warnings
May increase risk of thyroid C-cell tumors and pancreatitis; monitor appropriately.
How it works
GLP-1 receptor agonist that enhances glucose-dependent insulin secretion and reduces appetite.
Storage
Store according to labeled refrigeration and handling instructions.
